市场立即捐赠成为会员

购物车 (0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Ottawa Marriott Hotel

2017 年 10 月 17 日 7:00 上午 - 2017 年 10 月 18 日 3:00 下午

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

返回 Agenda

Session 6B: Real-World Data

Session Chair(s)

Lisa Chartrand

Lisa Chartrand

Director, Regulatory Strategy and Policy , Hoffmann-La Roche Limited, Canada

We hear a lot lately about real-world data and how it will revolutionize the way we think about evidence. As ICH have reflected on this concept already, it is time now for industry, regulators, and patients in Canada to start thinking about how this evidence will be used, how it will foster research and innovation, how it will help with regulatory decision-making throughout the product's life cycle and ideally, from the patient's perspective, and how it could expedite access of medicines by looking at partnerships with industry, as well as government stakeholders to explore its full potential.

Speaker(s)

Basanti Ghosh, PHD, MBA

Basanti Ghosh, PHD, MBA

HPFB Marketed Health Products Directorate (OPEDA), Health Canada, Canada

Health Canada: The Enhanced Use of Real-World Data

Vikesh Srivastava

Associate Director, Business Informatics Division, HPFB, Health Canada, Canada

Speaker

Michael Duong

Michael Duong

Director, Evidence Generation, Medical Affairs, Hoffmann-La Roche Limited, Canada

Real-World Evidence: An Industry Perspective

Barry D Stein

Barry D Stein

President and CEO, Coloretal Cancer Association of Canada, Canada

Should Real-World Data Impact Regulatory Decision-Making: A Patient’s Perspective